Truist Securities Maintains Buy on Ovintiv, Lowers Price Target to $66

Benzinga Newsdesk www.benzinga.com Neutral 50.4%

Neg 0% Neu 50.4% Pos 0%

Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and lowers the price target from $70 to $66.